Search

Your search keyword '"Yano, Hiromu"' showing total 44 results

Search Constraints

Start Over You searched for: Author "Yano, Hiromu" Remove constraint Author: "Yano, Hiromu"
44 results on '"Yano, Hiromu"'

Search Results

7. Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltration

10. Potential use of EGFR-targeted molecular therapies for tumor suppressor CYLD-negative and poor prognosis oral squamous cell carcinoma with chemoresistance

11. Involvement of ferroptosis‐defensive xCT/GPX4 axis in radioresistance and its impacts on prognosis in oral squamous cell carcinoma

14. Overexpression of SerpinB9 in non-seminomatous germ cell tumors

15. Dysfunction of sinus macrophages in tumor‐bearing host induces resistance to immunotherapy

16. Dysfunction of sinus macrophages in tumor‐bearing host induces resistance to immunotherapy.

17. Predictive value of CXCL10 for the occurrence of immune‐related adverse events in patient with renal cell carcinoma

19. Establishment and characterization of a novel cancer stem‐like cell of cholangiocarcinoma

20. Abstract 4326: Predictive value of CXCL10 for the occurrence of immune related adverse events in patient with renal cell carcinoma

22. Performance Comparison of Software Reliability Estimation Algorithms

23. Expression of macrophage/dendritic cell–related molecules in lymph node sinus macrophages.

25. Macrophage colony‐stimulating factor potentially induces recruitment and maturation of macrophages in recurrent pituitary neuroendocrine tumors

26. Iron accelerates Fusobacterium nucleatum–induced CCL8 expression in macrophages and is associated with colorectal cancer progression

27. SPP1 Derived from Macrophages Is Associated with a Worse Clinical Course and Chemo-Resistance in Lung Adenocarcinoma

29. Aging-associated and CD4 T-cell–dependent ectopic CXCL13 activation predisposes to anti–PD-1 therapy-induced adverse events

30. Blocking cholesterol efflux mechanism is a potential target for antilymphoma therapy

31. Additional file 1 of Potential use of EGFR-targeted molecular therapies for tumor suppressor CYLD-negative and poor prognosis oral squamous cell carcinoma with chemoresistance

32. Macrophage colony‐stimulating factor potentially induces recruitment and maturation of macrophages in recurrent pituitary neuroendocrine tumors.

38. Cell adhesion molecule-1 (CADM1) expressed on adult T-cell leukemia/lymphoma cells is not involved in the interaction with macrophages.

39. An IL‐27/Stat3 axis induces expression of programmed cell death 1 ligands ( PD ‐L1/2) on infiltrating macrophages in lymphoma

40. High density of CD204-positive macrophages predicts worse clinical prognosis in patients with breast cancer.

41. Age-associated reduction of sinus macrophages in human mesenteric lymph nodes.

42. Impacts of cytoplasmic p53 aggregates on the prognosis and the transcriptome in lung squamous cell carcinoma.

43. Anticancer immune reaction and lymph node sinus macrophages: a review from human and animal studies.

44. CXCL10 Expression in Human Colorectal Cancer Tissue and its Correlation With Serum Levels of CXCL10.

Catalog

Books, media, physical & digital resources